Amerindian genetic ancestry protects against Alzheimer's disease

Dement Geriatr Cogn Disord. 2012;33(5):311-7. doi: 10.1159/000339672. Epub 2012 Jul 2.

Abstract

Background: Alzheimer's disease (AD) is the most common form of dementia worldwide, and bears remarkable evidence for a differential prevalence among continental populations. In this scenario, estimating ancestry proportions in recently admixed populations is a strategy that can help increasing knowledge about the genetic structure of this complex trait.

Aim/methods: Our purpose was to assess mean ancestry estimates for the three main parental contributors to the Brazilian contingent (European, African and Amerindian) using a panel of 12 ancestry informative markers. Outpatients with the late-onset form of AD (n = 120) were compared for ancestry levels with non-cognitively impaired subjects (n = 412) in the Midwest Brazil, controlling for classic clinical, social and anthropometric risk factors.

Results: Our findings show a 3-fold greater genetic Amerindian content among control subjects compared to AD patients (p < 0.001).

Conclusion: Our results suggest that the allelic architecture of Native Americans can confer protection against the onset of the disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / genetics*
  • Apolipoprotein E4 / genetics
  • Black People / genetics*
  • Brazil
  • Case-Control Studies
  • Female
  • Gene Frequency
  • Genetic Markers
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Indians, South American / genetics*
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide
  • White People / genetics*

Substances

  • Apolipoprotein E4
  • Genetic Markers